Kaneka Corporation, the Japan based chemical manufacturing company, is set to appeal to the District Court for the Central District of California Decision in the U.S. Patent Infringement Lawsuit relating to Oxidized Coenzyme Q10.

Kaneka Corporation has been in dispute with pharmaceutical company, Xiamen Kingdomway Group Company, since March 2011, when Kaneka instituted a patent infringement action against the company in the United States District Court for the Central District of California alleging infringement of Kaneka's U.S. Patent No. 7,910,340 relating to coenzyme Q10 (Kaneka Q10™).